An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, risking fines, legal action or prison.
Service Response and Material Removal
According to the social media company, the service has removed problematic content and prohibited associated keywords and search suggestions. The company stated it was committed to maintaining the platform safe and investing in enhancing compliance measures.
Online Marketplace Operations
Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for mixing or injecting at residence.
After minutes of joining one group, a seller shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.
Item Details and Costs
Within these communities, messages display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how long a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered individuals injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant medical dangers”.
